Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EBT (2020 - 2025)

Cellebrite DI's EBT history spans 6 years, with the latest figure at $26.3 million for Q4 2025.

  • Quarterly EBT rose 32.03% to $26.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $90.7 million through Dec 2025, up 132.86% year-over-year, with the annual reading at $90.7 million for FY2025, 132.86% up from the prior year.
  • EBT came in at $26.3 million for Q4 2025, up from $24.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $54.5 million in Q1 2022 to a low of -$204.5 million in Q3 2024.
  • The 5-year median for EBT is $11.9 million (2021), against an average of -$2.9 million.
  • Year-over-year, EBT soared 1141.26% in 2022 and then plummeted 3086.38% in 2024.
  • Cellebrite DI's EBT stood at $54.1 million in 2021, then tumbled by 83.18% to $9.1 million in 2022, then plummeted by 235.63% to -$12.3 million in 2023, then surged by 261.17% to $19.9 million in 2024, then surged by 32.03% to $26.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's EBT are $26.3 million (Q4 2025), $24.3 million (Q3 2025), and $20.8 million (Q2 2025).